Login / Signup

Pseudo-halide anion engineering for α-FAPbI3 perovskite solar cells.

Jaeki JeongMinjin KimJongdeuk SeoHaizhou LuParamvir AhlawatAditya MishraYing-Guo YangMichael A HopeFelix T EickemeyerMaengsuk KimYung Jin YoonIn Woo ChoiBarbara Primera DarwichSeung Ju ChoiYimhyun JoJun Hee LeeBright WalkerShaik M ZakeeruddinLyndon EmsleyUrsula RothlisbergerAnders HagfeldtDong Suk KimMichael GrätzelJin Young Kim
Published in: Nature (2021)
Metal halide perovskites of the general formula ABX3-where A is a monovalent cation such as caesium, methylammonium or formamidinium; B is divalent lead, tin or germanium; and X is a halide anion-have shown great potential as light harvesters for thin-film photovoltaics1-5. Among a large number of compositions investigated, the cubic α-phase of formamidinium lead triiodide (FAPbI3) has emerged as the most promising semiconductor for highly efficient and stable perovskite solar cells6-9, and maximizing the performance of this material in such devices is of vital importance for the perovskite research community. Here we introduce an anion engineering concept that uses the pseudo-halide anion formate (HCOO-) to suppress anion-vacancy defects that are present at grain boundaries and at the surface of the perovskite films and to augment the crystallinity of the films. The resulting solar cell devices attain a power conversion efficiency of 25.6 per cent (certified 25.2 per cent), have long-term operational stability (450 hours) and show intense electroluminescence with external quantum efficiencies of more than 10 per cent. Our findings provide a direct route to eliminate the most abundant and deleterious lattice defects present in metal halide perovskites, providing a facile access to solution-processable films with improved optoelectronic performance.
Keyphrases
  • perovskite solar cells
  • room temperature
  • ionic liquid
  • highly efficient
  • solar cells
  • mental health
  • healthcare
  • quantum dots
  • bone marrow
  • mesenchymal stem cells
  • gold nanoparticles
  • preterm infants
  • reduced graphene oxide